← Back to all trials
Active Not Recruiting
NCT05095532
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Conditions: Chronic Pancreatitis, Mesenchymal Stem Cells
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE1
Enrollment: 42
Sponsor: Medical University of South Carolina
Location: Medical University of South Carolina Charleston South Carolina
Summary
This is a clinical trial for chronic pancreatitis (CP) patients undergoing total pancreatectomy with islet autotransplantation (TP-IAT). Participants will be randomized to either bone marrow-derived mesenchymal stem cells (MSCs) or control with the standard of care. Participants will be followed for one-year post-transplant.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of CP and scheduled for TP-IAT;
* ≥18 years old;
* Diabetes with HbA1c \3 times normal levels);
Source: ClinicalTrials.gov (NCT05095532). StuddyBuddy aggregates publicly available trial information.
